CVS
CVS Health Corporation
Price Chart
Latest Quote
$107.47
+0.97 (+0.91%)
Current Price
| Previous Close | $106.50 |
| Open | $107.36 |
| Day High | $108.96 |
| Day Low | $106.61 |
| Volume | 6,605,752 |
Stock Information
| Quarterly Dividend / Yield | $2.66 / 2.50% |
| Shares Outstanding | 1.28B |
| Quarterly Dividend Yield | 2.50% |
| Quarterly Dividend | $2.66 |
| Total Debt | $78.35B |
| Cash Equivalents | $11.80B |
| Revenue | $405.62B |
| Net Income | $2.93B |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $137.12B |
| P/E Ratio | 46.73 |
| EPS (TTM) | $2.30 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $203.85B |
| Sales | $405.62B |
| Income | $2.93B |
| Book/sh | $60.84 |
| Cash/sh | $9.25 |
| Employees | 219K |
Financial Ratios
| Quick Ratio | 0.61 |
| Current Ratio | 0.87 |
| Debt/Eq | 100.91 |
| EPS Growth TTM | 65.40% |
Returns & Margins
| ROA | 2.67% |
| ROE | 3.75% |
| Gross Margin | 13.39% |
| Operating Margin | 4.12% |
| Profit Margin | 0.72% |
Ownership
| Insider Ownership | 0.06% |
| Institutional Ownership | 90.20% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 12.78 |
| PEG | 0.30 |
| P/S | 0.34 |
| P/B | 1.77 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $111.92 |
Technical Indicators
| SMA20 | $103.92 |
| SMA50 | $98.32 |
| SMA200 | $82.29 |
| RSI | 61.00 |
| ATR | 2.5121 |
| Shares Float | 1.27B |
| Short Float | 1.57% |
| Short Ratio | 2.32 |
| Volatility | 0.60 |
| Rel Volume | 0.80 |
Performance History
| Week | +3.19% |
| Month | +6.70% |
| Quarter | +41.18% |
| 6 Months | +37.79% |
| YTD | +36.41% |
| Year | +74.61% |
| 3 Years | +71.35% |
| 5 Years | +55.98% |
| 10 Years | +50.79% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $107.47 | 6,607,100 |
| 2026-07-16 | $106.50 | 12,025,100 |
| 2026-07-15 | $105.91 | 6,939,400 |
| 2026-07-14 | $106.18 | 11,396,100 |
| 2026-07-13 | $105.90 | 7,264,400 |
| 2026-07-10 | $104.15 | 9,356,300 |
| 2026-07-09 | $102.81 | 8,474,200 |
| 2026-07-08 | $104.47 | 4,766,300 |
| 2026-07-07 | $104.33 | 4,967,000 |
| 2026-07-06 | $102.08 | 5,709,600 |
| 2026-07-02 | $104.72 | 5,522,600 |
| 2026-07-01 | $104.81 | 7,508,100 |
| 2026-06-30 | $103.45 | 5,623,500 |
| 2026-06-29 | $103.58 | 4,788,400 |
| 2026-06-26 | $104.34 | 9,690,500 |
| 2026-06-25 | $104.66 | 8,919,500 |
| 2026-06-24 | $101.87 | 8,491,200 |
| 2026-06-23 | $101.57 | 6,435,000 |
| 2026-06-22 | $101.30 | 9,810,600 |
| 2026-06-18 | $98.32 | 21,578,800 |
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
đ° Latest News
What A Patient Holder Is Really Paying For CVS Health Stock
Trefis âĸ 2026-07-17T22:09:52Z
What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?
Trefis âĸ 2026-07-17T22:02:00Z
CVS Health (CVS) Opens Its First Neighborhood Pharmacy In Houston
Simply Wall St. âĸ 2026-07-17T18:12:51Z
CVS Health CEO David Joyner warns private insurers won't cover GLP-1s for weight loss until drug prices drop
Moneywise âĸ 2026-07-17T18:00:00Z
How Much Of Your Portfolio Is Really CVS?
Trefis âĸ 2026-07-17T12:25:32Z
CVS Health (CVS) Stock Looks Pricey On FTC Insulin Settlement
Simply Wall St. âĸ 2026-07-17T05:10:14Z
How Investors May Respond To CVS (CVS) Dividend Move And GLPâ1 Strategy Across Its Health Platform
Simply Wall St. âĸ 2026-07-17T03:28:15Z
UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates
GuruFocus.com âĸ 2026-07-16T20:24:36ZCan Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?
Zacks âĸ 2026-07-16T16:53:00Z
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Zacks âĸ 2026-07-16T15:50:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $346,705,000,000 | $321,408,000,000 | $303,345,000,000 | $267,965,000,000 |
| Cost Of Revenue | $346,705,000,000 | $321,408,000,000 | $303,345,000,000 | $267,965,000,000 |
| Total Revenue | $402,067,000,000 | $372,809,000,000 | $357,776,000,000 | $322,467,000,000 |
| Operating Revenue | $402,067,000,000 | $372,809,000,000 | $357,776,000,000 | $322,467,000,000 |
| Expenses | ||||
| Interest Expense | $3,119,000,000 | $2,958,000,000 | $2,658,000,000 | $2,287,000,000 |
| Total Expenses | $391,682,000,000 | $363,114,000,000 | $343,177,000,000 | $306,177,000,000 |
| Other Income Expense | $-5,130,000,000 | $-589,000,000 | $-768,000,000 | $-8,167,000,000 |
| Other Non Operating Income Expenses | $112,000,000 | $99,000,000 | $88,000,000 | $169,000,000 |
| Net Non Operating Interest Income Expense | $-3,119,000,000 | $-2,958,000,000 | $-2,658,000,000 | $-2,287,000,000 |
| Interest Expense Non Operating | $3,119,000,000 | $2,958,000,000 | $2,658,000,000 | $2,287,000,000 |
| Operating Expense | $44,977,000,000 | $41,706,000,000 | $39,832,000,000 | $38,212,000,000 |
| Other Operating Expenses | $44,977,000,000 | $41,706,000,000 | $39,832,000,000 | $38,212,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,768,000,000 | $4,614,000,000 | $8,344,000,000 | $4,311,000,000 |
| Net Interest Income | $-3,119,000,000 | $-2,958,000,000 | $-2,658,000,000 | $-2,287,000,000 |
| Normalized Income | $6,008,778,000 | $5,127,248,000 | $8,985,144,000 | $10,487,976,000 |
| Net Income From Continuing And Discontinued Operation | $1,768,000,000 | $4,614,000,000 | $8,344,000,000 | $4,311,000,000 |
| Total Operating Income As Reported | $4,660,000,000 | $8,516,000,000 | $13,743,000,000 | $7,954,000,000 |
| Net Income Common Stockholders | $1,768,000,000 | $4,614,000,000 | $8,344,000,000 | $4,311,000,000 |
| Net Income | $1,768,000,000 | $4,614,000,000 | $8,344,000,000 | $4,311,000,000 |
| Net Income Including Noncontrolling Interests | $1,728,000,000 | $4,586,000,000 | $8,368,000,000 | $4,327,000,000 |
| Net Income Continuous Operations | $1,728,000,000 | $4,586,000,000 | $8,368,000,000 | $4,327,000,000 |
| Pretax Income | $2,136,000,000 | $6,148,000,000 | $11,173,000,000 | $5,836,000,000 |
| Special Income Charges | $-5,242,000,000 | $-688,000,000 | $-856,000,000 | $-8,336,000,000 |
| Operating Income | $10,385,000,000 | $9,695,000,000 | $14,599,000,000 | $16,290,000,000 |
| Gross Profit | $55,362,000,000 | $51,401,000,000 | $54,431,000,000 | $54,502,000,000 |
| Net Income Discontinuous Operations | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $1.39 | $3.66 | $6.47 | $3.26 |
| Basic EPS | $1.40 | $3.67 | $6.49 | $3.29 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,001,222,000 | $-174,752,000 | $-214,856,000 | $-2,159,024,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $15,103,000,000 | $14,391,000,000 | $19,053,000,000 | $20,683,000,000 |
| Total Unusual Items | $-5,242,000,000 | $-688,000,000 | $-856,000,000 | $-8,336,000,000 |
| Total Unusual Items Excluding Goodwill | $-5,242,000,000 | $-688,000,000 | $-856,000,000 | $-8,336,000,000 |
| Reconciled Depreciation | $4,606,000,000 | $4,597,000,000 | $4,366,000,000 | $4,224,000,000 |
| EBITDA (Bullshit earnings) | $9,861,000,000 | $13,703,000,000 | $18,197,000,000 | $12,347,000,000 |
| EBIT | $5,255,000,000 | $9,106,000,000 | $13,831,000,000 | $8,123,000,000 |
| Diluted Average Shares | $1,271,000,000 | $1,262,000,000 | $1,290,000,000 | $1,323,000,000 |
| Basic Average Shares | $1,267,000,000 | $1,259,000,000 | $1,285,000,000 | $1,312,000,000 |
| Diluted NI Availto Com Stockholders | $1,768,000,000 | $4,614,000,000 | $8,344,000,000 | $4,311,000,000 |
| Minority Interests | $40,000,000 | $28,000,000 | $-24,000,000 | $-16,000,000 |
| Tax Provision | $408,000,000 | $1,562,000,000 | $2,805,000,000 | $1,509,000,000 |
| Gain On Sale Of Ppe | $0 | $0 | $-349,000,000 | $-2,533,000,000 |
| Gain On Sale Of Business | $483,000,000 | $0 | $0 | - |
| Impairment Of Capital Assets | $5,725,000,000 | $0 | $0 | $0 |
| Restructuring And Mergern Acquisition | $0 | $1,179,000,000 | $507,000,000 | $0 |
| Other Special Charges | - | $-491,000,000 | - | $5,803,000,000 |
Fetched: 2026-06-26
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-35,772,000,000 | $-43,035,000,000 | $-44,045,000,000 | $-31,484,000,000 |
| Total Assets | $253,538,000,000 | $253,215,000,000 | $249,728,000,000 | $228,275,000,000 |
| Total Non Current Assets | $178,824,000,000 | $184,570,000,000 | $181,870,000,000 | $162,642,000,000 |
| Other Non Current Assets | $5,119,000,000 | $4,793,000,000 | $4,660,000,000 | $4,620,000,000 |
| Investmentin Financial Assets | $28,097,000,000 | $25,131,000,000 | $19,765,000,000 | $18,551,000,000 |
| Goodwill And Other Intangible Assets | $110,986,000,000 | $118,595,000,000 | $120,506,000,000 | $102,953,000,000 |
| Other Intangible Assets | $25,508,000,000 | $27,323,000,000 | $29,234,000,000 | $24,803,000,000 |
| Current Assets | $74,714,000,000 | $68,645,000,000 | $67,858,000,000 | $65,633,000,000 |
| Other Current Assets | $5,091,000,000 | $3,076,000,000 | $3,151,000,000 | $2,636,000,000 |
| Inventory | $19,246,000,000 | $18,107,000,000 | $18,025,000,000 | $19,090,000,000 |
| Receivables | $39,779,000,000 | $36,469,000,000 | $35,227,000,000 | $27,276,000,000 |
| Other Receivables | $23,463,000,000 | $21,857,000,000 | $19,605,000,000 | $15,617,000,000 |
| Accounts Receivable | $16,316,000,000 | $14,612,000,000 | $15,622,000,000 | $11,659,000,000 |
| Cash Cash Equivalents And Short Term Investments | $10,598,000,000 | $10,993,000,000 | $11,455,000,000 | $15,723,000,000 |
| Cash And Cash Equivalents | $8,453,000,000 | $8,586,000,000 | $8,196,000,000 | $12,945,000,000 |
| Assets Held For Sale Current | - | - | $0 | $908,000,000 |
| Debt | ||||
| Net Debt | $56,117,000,000 | $57,684,000,000 | $53,414,000,000 | $39,309,000,000 |
| Total Debt | $79,950,000,000 | $82,920,000,000 | $79,385,000,000 | $70,732,000,000 |
| Long Term Debt And Capital Lease Obligation | $74,145,000,000 | $75,426,000,000 | $74,672,000,000 | $67,276,000,000 |
| Long Term Debt | $60,502,000,000 | $60,527,000,000 | $58,638,000,000 | $50,476,000,000 |
| Current Debt And Capital Lease Obligation | $5,805,000,000 | $7,494,000,000 | $4,713,000,000 | $3,456,000,000 |
| Current Debt | $4,068,000,000 | $5,743,000,000 | $2,972,000,000 | $1,778,000,000 |
| Other Current Borrowings | $4,068,000,000 | $3,624,000,000 | $2,772,000,000 | $1,778,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $178,156,000,000 | $177,485,000,000 | $173,092,000,000 | $156,506,000,000 |
| Total Non Current Liabilities Net Minority Interest | $89,464,000,000 | $92,876,000,000 | $93,903,000,000 | $87,085,000,000 |
| Other Non Current Liabilities | $9,493,000,000 | $10,333,000,000 | $11,670,000,000 | $12,565,000,000 |
| Non Current Deferred Liabilities | $3,832,000,000 | $3,806,000,000 | $4,311,000,000 | $4,016,000,000 |
| Non Current Deferred Taxes Liabilities | $3,832,000,000 | $3,806,000,000 | $4,311,000,000 | $4,016,000,000 |
| Current Liabilities | $88,692,000,000 | $84,609,000,000 | $79,189,000,000 | $69,421,000,000 |
| Other Current Liabilities | $1,116,000,000 | $1,183,000,000 | $1,141,000,000 | $2,817,000,000 |
| Payables And Accrued Expenses | $81,771,000,000 | $75,932,000,000 | $73,335,000,000 | $63,148,000,000 |
| Payables | $59,384,000,000 | $55,122,000,000 | $49,820,000,000 | $44,403,000,000 |
| Other Payable | $41,743,000,000 | $39,230,000,000 | $34,923,000,000 | $29,565,000,000 |
| Accounts Payable | $17,641,000,000 | $15,892,000,000 | $14,897,000,000 | $14,838,000,000 |
| Equity | ||||
| Common Stock Equity | $75,214,000,000 | $75,560,000,000 | $76,461,000,000 | $71,469,000,000 |
| Total Equity Gross Minority Interest | $75,382,000,000 | $75,730,000,000 | $76,636,000,000 | $71,769,000,000 |
| Stockholders Equity | $75,214,000,000 | $75,560,000,000 | $76,461,000,000 | $71,469,000,000 |
| Gains Losses Not Affecting Retained Earnings | $406,000,000 | $-120,000,000 | $-297,000,000 | $-1,264,000,000 |
| Other Equity Adjustments | $406,000,000 | $-120,000,000 | $-297,000,000 | $-1,264,000,000 |
| Retained Earnings | $61,196,000,000 | $62,837,000,000 | $61,604,000,000 | $56,398,000,000 |
| Other | ||||
| Treasury Shares Number | $516,000,000 | $518,000,000 | $480,000,000 | $458,000,000 |
| Ordinary Shares Number | $1,271,000,000 | $1,260,000,000 | $1,288,000,000 | $1,300,000,000 |
| Share Issued | $1,787,000,000 | $1,778,000,000 | $1,768,000,000 | $1,758,000,000 |
| Tangible Book Value | $-35,772,000,000 | $-43,035,000,000 | $-44,045,000,000 | $-31,484,000,000 |
| Invested Capital | $139,784,000,000 | $141,830,000,000 | $138,071,000,000 | $123,723,000,000 |
| Working Capital | $-13,978,000,000 | $-15,964,000,000 | $-11,331,000,000 | $-3,788,000,000 |
| Capital Lease Obligations | $15,380,000,000 | $16,650,000,000 | $17,775,000,000 | $18,478,000,000 |
| Total Capitalization | $135,716,000,000 | $136,087,000,000 | $135,099,000,000 | $121,945,000,000 |
| Minority Interest | $168,000,000 | $170,000,000 | $175,000,000 | $300,000,000 |
| Treasury Stock | $36,790,000,000 | $36,818,000,000 | $33,838,000,000 | $31,858,000,000 |
| Capital Stock | $50,402,000,000 | $49,661,000,000 | $48,992,000,000 | $48,193,000,000 |
| Common Stock | $50,402,000,000 | $49,661,000,000 | $48,992,000,000 | $48,193,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $1,994,000,000 | $3,311,000,000 | $3,250,000,000 | $3,228,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $1,994,000,000 | $3,311,000,000 | $3,250,000,000 | $3,228,000,000 |
| Long Term Capital Lease Obligation | $13,643,000,000 | $14,899,000,000 | $16,034,000,000 | $16,800,000,000 |
| Current Capital Lease Obligation | $1,737,000,000 | $1,751,000,000 | $1,741,000,000 | $1,678,000,000 |
| Commercial Paper | $0 | $2,119,000,000 | $200,000,000 | $0 |
| Current Accrued Expenses | $22,387,000,000 | $20,810,000,000 | $23,515,000,000 | $18,745,000,000 |
| Defined Pension Benefit | $1,994,000,000 | $3,311,000,000 | $3,250,000,000 | $3,228,000,000 |
| Investments And Advances | $32,669,000,000 | $28,934,000,000 | $23,019,000,000 | $21,096,000,000 |
| Other Investments | $4,572,000,000 | $3,803,000,000 | $3,254,000,000 | $2,545,000,000 |
| Held To Maturity Securities | $1,376,000,000 | $1,354,000,000 | $1,183,000,000 | $989,000,000 |
| Available For Sale Securities | $26,721,000,000 | $23,777,000,000 | $18,582,000,000 | $17,562,000,000 |
| Goodwill | $85,478,000,000 | $91,272,000,000 | $91,272,000,000 | $78,150,000,000 |
| Net PPE | $28,056,000,000 | $28,937,000,000 | $30,435,000,000 | $30,745,000,000 |
| Accumulated Depreciation | $-24,744,000,000 | $-23,447,000,000 | $-20,699,000,000 | $-21,483,000,000 |
| Gross PPE | $52,800,000,000 | $52,384,000,000 | $51,134,000,000 | $52,228,000,000 |
| Leases | $6,812,000,000 | $6,725,000,000 | $6,511,000,000 | $6,238,000,000 |
| Other Properties | $14,973,000,000 | $15,944,000,000 | $17,252,000,000 | $17,628,000,000 |
| Machinery Furniture Equipment | $24,613,000,000 | $23,236,000,000 | $20,842,000,000 | $21,821,000,000 |
| Buildings And Improvements | $4,593,000,000 | $4,632,000,000 | $4,571,000,000 | $4,545,000,000 |
| Land And Improvements | $1,809,000,000 | $1,847,000,000 | $1,958,000,000 | $1,996,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $2,145,000,000 | $2,407,000,000 | $3,259,000,000 | $2,778,000,000 |
| Inventories Adjustments Allowances | - | - | $-607,000,000 | $-559,000,000 |
| Other Inventories | - | - | $18,632,000,000 | $19,649,000,000 |
Fetched: 2026-06-26
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $7,807,000,000 | $6,326,000,000 | $10,395,000,000 | $13,450,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $10,639,000,000 | $9,107,000,000 | $13,426,000,000 | $16,177,000,000 |
| Cash Flow From Continuing Operating Activities | $10,639,000,000 | $9,107,000,000 | $13,426,000,000 | $16,177,000,000 |
| Operating Gains Losses | $-247,000,000 | $-491,000,000 | $349,000,000 | $2,058,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,832,000,000 | $-2,781,000,000 | $-3,031,000,000 | $-2,727,000,000 |
| Investing Cash Flow | $-5,871,000,000 | $-7,613,000,000 | $-20,889,000,000 | $-5,047,000,000 |
| Cash Flow From Continuing Investing Activities | $-5,871,000,000 | $-7,613,000,000 | $-20,889,000,000 | $-5,047,000,000 |
| Net Other Investing Changes | $26,000,000 | $101,000,000 | $68,000,000 | $85,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-3,023,000,000 | $-2,012,000,000 | $-3,500,000,000 |
| Financing Cash Flow | $-4,940,000,000 | $-1,135,000,000 | $2,683,000,000 | $-10,516,000,000 |
| Cash Flow From Continuing Financing Activities | $-4,940,000,000 | $-1,135,000,000 | $2,683,000,000 | $-10,516,000,000 |
| Net Other Financing Charges | $-158,000,000 | $-159,000,000 | $-382,000,000 | $-449,000,000 |
| Cash Dividends Paid | $-3,397,000,000 | $-3,373,000,000 | $-3,132,000,000 | $-2,907,000,000 |
| Common Stock Dividend Paid | $-3,397,000,000 | $-3,373,000,000 | $-3,132,000,000 | $-2,907,000,000 |
| Net Common Stock Issuance | $0 | $-3,023,000,000 | $-2,012,000,000 | $-3,500,000,000 |
| Other | ||||
| Repayment Of Debt | $-5,748,000,000 | $-4,773,000,000 | $-8,166,000,000 | $-4,211,000,000 |
| Issuance Of Debt | $3,969,000,000 | $9,832,000,000 | $16,098,000,000 | $0 |
| End Cash Position | $8,712,000,000 | $8,884,000,000 | $8,525,000,000 | $13,305,000,000 |
| Beginning Cash Position | $8,884,000,000 | $8,525,000,000 | $13,305,000,000 | $12,691,000,000 |
| Changes In Cash | $-172,000,000 | $359,000,000 | $-4,780,000,000 | $614,000,000 |
| Proceeds From Stock Option Exercised | $394,000,000 | $361,000,000 | $277,000,000 | $551,000,000 |
| Common Stock Payments | $0 | $-3,023,000,000 | $-2,012,000,000 | $-3,500,000,000 |
| Net Issuance Payments Of Debt | $-1,779,000,000 | $5,059,000,000 | $7,932,000,000 | $-4,211,000,000 |
| Net Short Term Debt Issuance | $-2,119,000,000 | $1,919,000,000 | $200,000,000 | $0 |
| Short Term Debt Payments | $-2,119,000,000 | $0 | $-5,000,000,000 | $0 |
| Short Term Debt Issuance | $0 | $1,919,000,000 | $5,200,000,000 | $0 |
| Net Long Term Debt Issuance | $340,000,000 | $3,140,000,000 | $7,732,000,000 | $-4,211,000,000 |
| Long Term Debt Payments | $-3,629,000,000 | $-4,773,000,000 | $-3,166,000,000 | $-4,211,000,000 |
| Long Term Debt Issuance | $3,969,000,000 | $7,913,000,000 | $10,898,000,000 | $0 |
| Net Investment Purchase And Sale | $-2,629,000,000 | $-4,838,000,000 | $-1,314,000,000 | $-1,017,000,000 |
| Sale Of Investment | $12,383,000,000 | $10,353,000,000 | $7,729,000,000 | $6,729,000,000 |
| Purchase Of Investment | $-15,012,000,000 | $-15,191,000,000 | $-9,043,000,000 | $-7,746,000,000 |
| Net Business Purchase And Sale | $-436,000,000 | $-95,000,000 | $-16,612,000,000 | $-1,388,000,000 |
| Purchase Of Business | $-436,000,000 | $-95,000,000 | $-16,612,000,000 | $-1,388,000,000 |
| Net PPE Purchase And Sale | $-2,832,000,000 | $-2,781,000,000 | $-3,031,000,000 | $-2,727,000,000 |
| Purchase Of PPE | $-2,832,000,000 | $-2,781,000,000 | $-3,031,000,000 | $-2,727,000,000 |
| Change In Working Capital | $-1,474,000,000 | $109,000,000 | $15,000,000 | $6,818,000,000 |
| Change In Other Current Liabilities | $2,013,000,000 | $-3,542,000,000 | $1,540,000,000 | $6,463,000,000 |
| Change In Other Current Assets | $-2,593,000,000 | $-38,000,000 | $-510,000,000 | $-491,000,000 |
| Change In Payables And Accrued Expense | $3,871,000,000 | $5,092,000,000 | $4,012,000,000 | $5,252,000,000 |
| Change In Payable | $3,871,000,000 | $5,092,000,000 | $4,012,000,000 | $5,252,000,000 |
| Change In Account Payable | $3,855,000,000 | $2,335,000,000 | $3,618,000,000 | $4,260,000,000 |
| Change In Inventory | $-1,267,000,000 | $-102,000,000 | $1,233,000,000 | $-1,435,000,000 |
| Change In Receivables | $-3,498,000,000 | $-1,301,000,000 | $-6,260,000,000 | $-2,971,000,000 |
| Changes In Account Receivables | $-3,498,000,000 | $-1,301,000,000 | $-6,260,000,000 | $-2,971,000,000 |
| Other Non Cash Items | $-336,000,000 | $-502,000,000 | $264,000,000 | $332,000,000 |
| Stock Based Compensation | $535,000,000 | $540,000,000 | $588,000,000 | $447,000,000 |
| Asset Impairment Charge | $5,725,000,000 | $840,000,000 | $152,000,000 | $0 |
| Deferred Tax | $102,000,000 | $-572,000,000 | $-676,000,000 | $-2,029,000,000 |
| Deferred Income Tax | $102,000,000 | $-572,000,000 | $-676,000,000 | $-2,029,000,000 |
| Depreciation Amortization Depletion | $4,606,000,000 | $4,597,000,000 | $4,366,000,000 | $4,224,000,000 |
| Depreciation And Amortization | $4,606,000,000 | $4,597,000,000 | $4,366,000,000 | $4,224,000,000 |
| Gain Loss On Sale Of Business | $-247,000,000 | $0 | $0 | $-475,000,000 |
| Net Income From Continuing Operations | $1,728,000,000 | $4,586,000,000 | $8,368,000,000 | $4,327,000,000 |
| Sale Of Business | - | $0 | $0 | - |
| Sale Of PPE | - | - | - | $0 |
Fetched: 2026-06-26